Eurotimes Articles



Alamedics say the ala®heavy 1.07 is an innovative, heavy oil which can be used for the treatment of inferior retinal detachments as well as persistent macula holes. 
“What has to be highlighted is the renouncement of surfactants, density enhancers or other additives. ala®heavy 1.07 is made of one single component: pure, transparent, fluorinated silicone oil,” said a company spokesman. 

The Sail Hotel__WEB

Mies Pavelo

More cost-effective screening programmes are urgently needed to deal with the expected increase in diabetes worldwide over the coming decades, Einar Stefánsson MD, PhD told delegates attending the 14th EURETINA Congress in London.

Performing a glued intraocular lens (IOL) is a challenge in patients who have either larger or smaller than normal eyes. The challenge in large eyes is to get a sufficient degree of haptic exteriorised, resulting in insufficient haptic tuck and a potentially unstable IOL.

Image 1__WEB

Recent clinical trials of topically administrated nerve growth factor (NGF) demonstrate that the ocular surface healing and immune-modulating actions of NGF could have widespread therapeutic applications in a wide range of ocular diseases, according to Paolo Rama MD.

Abbott Medical Optics think their new Tecnis Symfony intraocular lens (IOL), approved for use in Europe, can do what multifocal IOLs have not – convince more cataract patients to try presbyopia-correcting lenses.


In the six years since the dawn of femtosecond laser-assisted cataract surgery (FLACS), precise capsulotomies have been touted as one of its biggest advantages. Perfectly sized, shaped and centred anterior capsule openings should help position and stabilise intraocular lenses (IOLs), leading to more predictable effective lens position and better visual outcomes, proponents say.

Popular Items